Over the last six months, Exponent’s shares have sunk to $69.66, producing a disappointing 17.2% loss - a stark contrast to ...

Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday afternoon. Here’s what to expect. Exponent beat analysts’ revenue expectations by 2.1% last quarter, ...

Last week, you might have seen that Exponent, Inc. (NASDAQ:EXPO) released its quarterly result to the market. The early response was not positive, with shares down 7.2% to US$69.59 in the past week.

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

A number of stocks fell in the morning session after a surprisingly weak U.S. jobs report was released, fueling concerns about a slowing economy. The U.S. economy added only 73,000 jobs, falling ...

Investors might want to bet on Exponent (EXPO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

The market expects Exponent (EXPO) to deliver a year-over-year increase in earnings on higher revenues when i t report s results for the quarter ended December 2018. This widely-known consensus ...